Estrogen augments glucose transporter and IGF1 expression in primate cerebral cortex
The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Estrogen has many positive effects on neural tissue in experimental model systems, including stimulation of neurite growth and neurotransmitter synthesis and protection against diverse types of neural injury. In humans, estrogen treatment is reputed to protect against Alzheimer's disease. To investigate potential mediators of estrogen's action and determine whether selective estrogen receptor modulators (SERMs) such as tamoxifen have estrogen-like effects in the primate brain, we evaluated the expression of glucose transporters and insulin-like growth factor 1 (IGF1) and its receptor in the frontal cortex of ovariectomized rhesus monkeys. We treated one group for 3 days with vehicle, another with 17 beta estradiol (E2), and a third with tamoxifen. The expression of facilitative glucose transporters (Gluts) 1, 3, and 4 was investigated using in situ hybridization, immunohistochemistry, and immunoblot analysis. Gluts 3 and 4 were concentrated in cortical neurons and Glut1 in capillaries and glial cells. E2 treatment induced two- to fourfold increases in Glut3 and Glut4 mRNA levels and lesser but significant increases in Glut3 and 4 protein levels. E2 treatment induced an approximately 70% increase in parenchymal Glut1 mRNA levels, but did not appreciably affect vascular Glut1 gene expression. IGF1 and IGF1 receptor mRNAs were concentrated in cortical neurons in a distribution similar to Gluts 3 and 4. IGF1 mRNA levels were significantly increased in E2-treated animals but IGF1 receptor mRNA levels were not altered by hormone treatment. Tamoxifen increased cerebral cortical Glut3 and 4 mRNA levels, but did not affect Glut1, IGF1, or IGF1 receptor expression. This study provides novel data showing that Gluts 3 and 4 and IGF1 are coexpressed by primate cerebral cortical neurons, where their expression is enhanced by estrogen. These findings suggest that up-regulation of glucose transporter and IGF1 expression may contribute to estrogen's salutary effects on neural tissue. Tamoxifen, an antiestrogen at the breast, is shown to have estrogen-like effects on higher brain centers in the monkey, suggesting that some SERMs may share estrogen's neuroprotective potential for menopausal women.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Estrogens and estrogen receptors regulate various aspects of glucose and lipid metabolism.”
From Estrogen deficiency and the origin of obesity during menopause (2014) · cites this paper as [114]
Citations
Cites
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
GROWTH FACTOR RECEPTOR TYROSINE KINASES
Yarden, Y., & Ullrich, A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.002303 · Cited by 1,838 · cited 1×
“Moreover, the IGF1 and insulin receptors are homologous, with ;85% identity in the intracellular, signal-transducing portion of the receptors (45, 46).”
BackgroundImpaired immune and acute-phase responses in interleukin-6-deficient mice
Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Estrogen Actions in the Central Nervous System1
McEwen, B. S., & Alves, S. E. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0365 · Cited by 1,358 · cited 1×
“anabolic effects on neural tissue (4) are identical to”
BackgroundInterleukin-6 family of cytokines and gp130
Kishimoto, T., Akira, S., Narazaki, M., & Taga, T. (1995) · Blood · doi:10.1182/blood.v86.4.1243.bloodjournal8641243 · Cited by 1,272
Schindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Stahl, N., Farruggella, T. J., Boulton, T. G., Zhong, Z., Darnell, J. E., & Yancopoulos, G. D. (1995) · Science · doi:10.1126/science.7871433 · Cited by 979
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Lütticken, C., Wegenka, U. M., Yuan, J., Buschmann, J., Schindler, C., Ziemiecki, A., Harpur, A. G., Wilks, A. F., Yasukawa, K., Taga, T., et al. (1994) · Science · doi:10.1126/science.8272872 · Cited by 814
Increased plasma levels of interleukin-6 in sepsis [see comments]
Hack, C., De Groot, E., Felt-Bersma, R., Nuijens, J., Strack Van Schijndel, R., Eerenberg-Belmer, A., Thijs, L., & Aarden, L. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
IL-6-Induced Homodimerization of gp130 and Associated Activation of a Tyrosine Kinase
Murakami, M., Hibi, M., Nakagawa, N., Nakagawa, T., Yasukawa, K., Yamanishi, K., Taga, T., & Kishimoto, T. (1993) · Science · doi:10.1126/science.8511589 · Cited by 724
Basic Guide to the Mechanisms of Antiestrogen Action
Macgregor, J. I., & Jordan, V. C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01358-9 · Cited by 694 · cited 3×
“Originally developed as an antiestrogen (67), tamox-”
BackgroundInfluentialEstrogen Actions in the Central Nervous System
McEwen, B. S. (1999) · Endocrine Reviews · doi:10.1210/er.20.3.279 · Cited by 640
Yoshida, K., Taga, T., Saito, M., Suematsu, S., Kumanogoh, A., Tanaka, T., Fujiwara, H., Hirata, M., Yamagami, T., Nakahata, T., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.407 · Cited by 635
LIFRβ and gp130 as Heterodimerizing Signal Transducers of the Tripartite CNTF Receptor
Davis, S., Aldrich, T. H., Stahl, N., Pan, L., Taga, T., Kishimoto, T., Ip, N. Y., & Yancopoulos, G. D. (1993) · Science · doi:10.1126/science.8390097 · Cited by 634
Nakajima, T., Kinoshita, S., Sasagawa, T., Sasaki, K., Naruto, M., Kishimoto, T., & Akira, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2207 · Cited by 578
Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides
Xu, H., Gouras, G. K., Greenfield, J. P., Vincent, B., Naslund, J., Mazzarelli, L., Fried, G., Jovanovic, J. N., Seeger, M., Relkin, N. R., et al. (1998) · Nature Medicine · doi:10.1038/nm0498-447 · Cited by 560
Disruption of the CNTF gene results in motor neuron degeneration
Masu, Y., Wolf, E., Holtmann, B., Sendtner, M., Brem, G., & Thoenen, H. (1993) · Nature · doi:10.1038/365027a0 · Cited by 558
Poli, G., Bressler, P., Kinter, A., Duh, E., Timmer, W. C., Rabson, A., Justement, J. S., Stanley, S., & Fauci, A. S. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.1.151 · Cited by 512
Simpson, I. A., Chundu, K. R., Davies‐Hill, T., Honer, W. G., & Davies, P. (1994) · Annals of Neurology · doi:10.1002/ana.410350507 · Cited by 490 · cited 1×
“It is worth noting that brain Glut1 and 3 levels (Glut4 was not evaluated) are significantly reduced in subjects with Alzheimer’s disease (69), suggesting one way in which estrogen may address the Alzheimer’s neuropathology.”
BackgroundMurphy, D. D., Cole, N. B., Greenberger, V., & Segal, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-07-02550.1998 · Cited by 460 · cited 1×
“neurite outgrowth (13, 14) and expression of acetylcho-”
BackgroundSoluble cytokine receptors are present in normal human urine.
Novick, D., Engelmann, H., Wallach, D., & Rubinstein, M. (1989) · The Journal of experimental medicine · doi:10.1084/jem.170.4.1409 · Cited by 434
Pennica, D., Shaw, K. J., Swanson, T. A., Moore, M. W., Shelton, D. L., Zioncheck, K. A., Rosenthal, A., Taga, T., Paoni, N. F., & Wood, W. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10915 · Cited by 429
IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade
Ogata, A., Chauhan, D., Teoh, G., Treon, S. P., Urashima, M., Schlossman, R. L., & Anderson, K. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.5.2212 · Cited by 399
Insulin-like growth factors cross the blood-brain barrier
Reinhardt, R., & Bondy, C. A. (1994) · Endocrinology · doi:10.1210/en.135.5.1753 · Cited by 391 · cited 5×
“One earlier study reported estrogen-induced increases in Glut1 expression in the BBB of the rat (29); however, the investigators examined time points within 24 h after a single E2 injection whereas we examined brains after 3 days of sustained treatment.”
BackgroundSelf-citationPike, C. J. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721552.x · Cited by 387
Escary, J.-L., Perreau, J., Duménil, D., Ezine, S., & Brûlet, P. (1993) · Nature · doi:10.1038/363361a0 · Cited by 364
Boulton, T. G., Stahl, N., & Yancopoulos, G. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)78174-5 · Cited by 361
Blood-brain barrier transcytosis of insulin in developing rabbits
Duffy, K. R., & Pardridge, W. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)90236-8 · Cited by 358 · cited 5×
“One earlier study reported estrogen-induced increases in Glut1 expression in the BBB of the rat (29); however, the investigators examined time points within 24 h after a single E2 injection whereas we examined brains after 3 days of sustained treatment.”
BackgroundInfluentialMyers, M. G. (1993) · Endocrinology · doi:10.1210/en.132.4.1421 · Cited by 333
Human soluble IL-6 receptor: its detection and enhanced release by HIV infection
Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Osugi, Y., Tokunaga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2175 · Cited by 331
The Insulin-Like Growth Factor-I Receptor
De Meyts, P., Wallach, B., Christoffersen, C. T., Ursø, B., Grønskov, K., Latus, L.-J., Yakushiji, F., Ilondo, M., & Shymko, R. M. (1994) · Hormone Research · doi:10.1159/000184188 · Cited by 320
Berman, K. F., Schmidt, P. J., Rubinow, D. R., Danaceau, M. A., Van Horn, J. D., Esposito, G., Ostrem, J. L., & Weinberger, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8836 · Cited by 318 · cited 2×
“Recent clinical studies have shown that cerebral glucose utilization is increased in estrogen-treated menopausal women (16, 17), in the high-estrogen phase of the menstrual cycle (60), and in menstruating women compared with men (61).”
BackgroundGerhartz, C., Heesel, B., Sasse, J., Hemmann, U., Landgraf, C., Schneider-Mergener, J., Horn, F., Heinrich, P. C., & Graeve, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12991 · Cited by 307
Blood—Brain Barrier Glucose Transporter: Effects of Hypo‐ and Hyperglycemia Revisited
Simpson, I. A., Appel, N. M., Hokari, M., Oki, J., Holman, G. D., Maher, F., Koehler‐Stec, E. M., Vannucci, S. J., & Smith, Q. R. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720238.x · Cited by 304 · cited 1×
“emia (25, 27), systemic hypoglycemia (28), and estro-”
BackgroundBondy, C. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-11-03442.1991 · Cited by 284 · cited 3×
“Since IGF1 is concentrated in the most metabolically active neurons (47), we have proposed that IGF1 functions as the brain’s endogenous insulin (48) and, similar to insulin, may regulate glucose transporter expression.”
BackgroundMethodSelf-citationSaito, M., Yoshida, K., Hibi, M., Taga, T., & Kishimoto, T. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.12.4066 · Cited by 282
Peters, M., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Meyer zum Büschenfelde, K. H., & Rose-John, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1399 · Cited by 276
Nagamatsu, S., Kornhauser, J. M., Burant, C. F., Seino, S., Mayo, K. E., & Bell, G. I. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48518-3 · Cited by 262
Novel neurotrophin-1/B cell-stimulating factor-3: A cytokine of the IL-6 family
Senaldi, G., Varnum, B. C., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo, J., Elliott, G., McNinch, J., Shaklee, C. L., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11458 · Cited by 251
Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death
Sawada, H., Ibi, M., Kihara, T., Urushitani, M., Akaike, A., & Shimohama, S. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5<707::aid-jnr16>3.0.co;2-t · Cited by 248 · cited 1×
“protection against toxic effects of oxidative stress (8, 9)”
BackgroundUlich, T. R., Yin, S., Guo, K., Yi, E. S., Remick, D. G., & del Castillo, J. M. G. (1991) · PubMed Central · Cited by 241
Protective role of interleukin 6 in the lipopolysaccharide-galactosamine septic shock model
Barton, B. E., & Jackson, J. V. (1993) · Infection and Immunity · doi:10.1128/iai.61.4.1496-1499.1993 · Cited by 200
Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6.
Baumann, H., & Schendel, P. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54940-1 · Cited by 199
Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, M., Davis, S., Shoyab, M., Yancopoulos, G. D., & Kishimoto, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10998 · Cited by 198
GLUT4 glucose transporter expression in rodent brain: effect of diabetes
Vannucci, S. J., Koehler-Stec, E. M., Li, K., Reynolds, T. H., Clark, R., & Simpson, I. A. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00103-6 · Cited by 193
Effects of estrogen in the CNS
Woolley, C. S. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)80051-8 · Cited by 192
Azcoitia, Í., Sierra, A., & García‐Segura, L. M. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991215)58:6<815::aid-jnr8>3.0.co;2-r · Cited by 190
The role of estrogen in the treatment of Alzheimer's disease
Birge, S. J. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_7.36s · Cited by 184
Pozzo-Miller, L. D., Inoue, T., & Murphy, D. D. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.3.1404 · Cited by 179 · cited 1×
“neurite outgrowth (13, 14) and expression of acetylcho-”
BackgroundCytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6
Guillen, I., Blanes, M., Gomez-Lechon, M. J., & Castell, J. V. (1995) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1995.269.2.r229 · Cited by 179
Apelt, J., Mehlhorn, G., & Schliebs, R. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5<693::aid-jnr11>3.0.co;2-x · Cited by 178
(1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01036-3 · Cited by 177
Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase
Xu, Y., Stokes, A. H., Roskoski, R., & Vrana, K. E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5<691::aid-jnr14>3.0.co;2-f · Cited by 175
Harik, S., Kalaria, R., Andersson, L., Lundahl, P., & Perry, G. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-12-03862.1990 · Cited by 170 · cited 6×
“One earlier study reported estrogen-induced increases in Glut1 expression in the BBB of the rat (29); however, the investigators examined time points within 24 h after a single E2 injection whereas we examined brains after 3 days of sustained treatment.”
BackgroundInfluentialCerebral glucose metabolic rates in normal human females versus normal males
Baxter, L. R., Mazziotta, J. C., Phelps, M. E., Selin, C. E., Guze, B. H., & Fairbanks, L. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90028-x · Cited by 165 · cited 1×
“Recent clinical studies have shown that cerebral glucose utilization is increased in estrogen-treated menopausal women (16, 17), in the high-estrogen phase of the menstrual cycle (60), and in menstruating women compared with men (61).”
BackgroundSzekanecz, Z., Shah, M. R., Pearce, W. H., & Koch, A. E. (1994) · Inflammation Research · doi:10.1007/bf01983484 · Cited by 161
Ernst, M., Gearing, D. P., & Dunn, A. R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06420.x · Cited by 160
Bartlett, W. P., Li, X.-S., Williams, M., & Benkovic, S. J. (1991) · Developmental Biology · doi:10.1016/s0012-1606(05)80021-1 · Cited by 159 · cited 1×
“IGF1 is highly expressed in the developing murine brain, where it is concentrated in maturing projection neurons (47, 62).”
BackgroundSelective oestrogen receptor modulation
Levenson, A. S., & Jordan, V. C. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00297-x · Cited by 156
Gibbs, R. B. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6789 · Cited by 150
Periventricular hypothalamic cells in the rat brain contain insulin mRNA
Young, W. S. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90035-1 · Cited by 148
Matsuda, T., Takahashi-Tezuka, M., Fukada, T., Okuyama, Y., Fujitani, Y., Tsukada, S., Mano, H., Hirai, H., Witte, O., & Hirano, T. (1995) · Blood · doi:10.1182/blood.v85.3.627.bloodjournal853627 · Cited by 146
Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism
Boulware, S. D., Tamborlane, W. V., Matthews, L. S., & Sherwin, R. S. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.262.1.e130 · Cited by 145
Matsuda, T., Fukada, T., Takahashi-Tezuka, M., Okuyama, Y., Fujitani, Y., Hanazono, Y., Hirai, H., & Hirano, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11037 · Cited by 143
Bondy, C. A., & Lee, W. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb26203.x · Cited by 139
Self-citationInestrosa, N. C., Marzolo, M., & Bonnefont, A. (1998) · Molecular Neurobiology · doi:10.1007/bf02802025 · Cited by 137
Estrogen Hormones Reduce Lipid Peroxidation in Cells and Tissues of the Central Nervous System
Vedder, H., Anthes, N., Stumm, G., Würz, C., Behl, C., & Krieg, J. ‐. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722531.x · Cited by 134 · cited 1×
“protection against toxic effects of oxidative stress (8, 9)”
BackgroundExpression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain
Maher, F., Vannucci, S. J., Takeda, J., & Simpson, I. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91789-s · Cited by 133
Discrete brain areas express the insulin-responsive glucose transporter GLUT4
Leloup, C., Arluison, M., Kassis, N., Lepetit, N., Cartier, N., Ferré, P., & Pénicaud, L. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00306-d · Cited by 131
Chen, H., Wertheimer, S. J., Lin, C. H., Katz, S. L., Amrein, K. E., Burn, P., & Quon, M. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8026 · Cited by 130
Placental glucose transporter gene expression and metabolism in the rat.
Zhou, J., & Bondy, C. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116305 · Cited by 125 · cited 2×
“The in situ hybridization protocol has been detailed (47) and the Glut1, 3, and 4, IGF1 receptor, and IGF1 cDNAs used for RNA probe synthesis have been described elsewhere (49, 50).”
BackgroundMethodSelf-citationNeurons and microvessels express the brain glucose transporter protein GLUT3.
Gerhart, D. Z., Broderius, M. A., Borson, N. D., & Drewes, L. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.733 · Cited by 121
WERNER, H., RAIZADA, M. K., MUDD, L. M., FOYT, H. L., SIMPSON, I. A., ROBERTS, C. T., & LEROITH, D. (1989) · Endocrinology · doi:10.1210/endo-125-1-314 · Cited by 121
Insulin-like growth factor 1 is required for G 2 progression in the estradiol-induced mitotic cycle
Adesanya, O. O., Zhou, J., Samathanam, C., Powell-Braxton, L., & Bondy, C. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3287 · Cited by 120
Self-citationEstrogen receptor-dependent regulation of sensory neuron survival in developing dorsal root ganglion
Patrone, C., Andersson, S., Korhonen, L., & Lindholm, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10905 · Cited by 119 · cited 1×
“including promotion of neuronal survival (6, 7) and”
BackgroundThe brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier
Boado, R. J., & Pardridge, W. M. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91927-k · Cited by 118
Fast, convenient, and effective method to transiently transfect primary hippocampal neurons
Köhrmann, M., Haubensak, W., Hemraj, I., Kaether, C., Leßmann, V. J., & Kiebler, M. A. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991215)58:6<831::aid-jnr10>3.0.co;2-m · Cited by 112
Lineage restriction of neuroepithelial precursor cells from fetal human spinal cord
Quinn, S. M., Walters, W. M., Vescovi, A. L., & Whittemore, S. R. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990901)57:5<590::aid-jnr2>3.0.co;2-x · Cited by 107
Cheng, C. M., Joncas, G., Reinhardt, R. R., Farrer, R., Quarles, R., Janssen, J., McDonald, M. P., Crawley, J. N., Powell-Braxton, L., & Bondy, C. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-15-05673.1998 · Cited by 105 · cited 2×
“Immunohistochemistry for Glut1, 3, and 4 was performed by the avidin-biotin-immunoperoxidase technique, as described previously (51).”
MethodSelf-citationTamoxifen for the prevention of breast cancer
Fisher, B., Powles, T. J., & Pritchard, K. J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00269-5 · Cited by 102
Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain
Kobayashi, M., Nikami, H., Morimatsu, M., & Saito, M. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12845-7 · Cited by 97
Molecular Actions of Insulin on Glucose Transport
Czech, M. P. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.002301 · Cited by 95 · cited 1×
“tissue in response to insulin action (37).”
Tissue distribution and species difference of the brain type glucose transporter (GLUT3)
Yano, H., Seino, Y., Inagaki, N., Hinokio, Y., Yamamoto, T., Yasuda, K., Masuda, K., Someya, Y., & Imura, H. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91440-n · Cited by 95 · cited 1×
“A previous study has reported Glut3 mRNA expression in monkey cortical neurons (32).”
BackgroundIschemic injury induces brain glucose transporter gene expression
Lee, W. H. (1993) · Endocrinology · doi:10.1210/en.133.6.2540 · Cited by 94 · cited 4×
“cyte marker in the rat (27), and others have recently”
BackgroundSelf-citationOntogeny and cellular distribution of brain glucose transporter gene expression
Bondy, C. A., Lee, W., & Zhou, J. (1992) · Molecular and Cellular Neuroscience · doi:10.1016/1044-7431(92)90027-y · Cited by 94 · cited 1×
“This pattern is similar to that we have described for Glut1 expression in the rat brain (20, 27).”
Self-citation17 beta-Estradiol modulation of glucose transporter 1 expression in blood-brain barrier
Shi, J., & Simpkins, J. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.272.6.e1016 · Cited by 93
Yu, S., & Ding, W. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00372-2 · Cited by 92 · cited 1×
“expression of Glut1 immunoreactivity (24, 25), so it”
BackgroundForebrain Ischemia Increases Glut1 Protein in Brain Microvessels and Parenchyma
McCall, A. L., Van Bueren, A. M., Nipper, V., Moholt-Siebert, M., Downes, H., & Lessov, N. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00008 · Cited by 90 · cited 2×
“expression of Glut1 immunoreactivity (24, 25), so it”
BackgroundThe effects of 17β-estradiol on ischemia-induced neuronal damage in the gerbil hippocampus
Chen, J., Adachi, N., Liu, K., & Arai, T. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00198-5 · Cited by 84 · cited 1×
“including promotion of neuronal survival (6, 7) and”
BackgroundBonnefont, A. B., Muñoz, F. J., & Inestrosa, N. C. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01552-x · Cited by 82
Kumar, G., Gupta, S., Wang, S., & Nel, A. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4436 · Cited by 80
The application of positron emission tomography to the study of the normal menstrual cycle
Reiman, E. M., Armstrong, S. M., Matt, K. S., & Mattox, J. H. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019214 · Cited by 78 · cited 1×
“Recent clinical studies have shown that cerebral glucose utilization is increased in estrogen-treated menopausal women (16, 17), in the high-estrogen phase of the menstrual cycle (60), and in menstruating women compared with men (61).”
BackgroundChin, E., Zhou, J., & Bondy, C. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116392 · Cited by 77 · cited 2×
“The in situ hybridization protocol has been detailed (47) and the Glut1, 3, and 4, IGF1 receptor, and IGF1 cDNAs used for RNA probe synthesis have been described elsewhere (49, 50).”
BackgroundMethodSelf-citationDifferential glycosylation of the GLUT1 glucose transporter in brain capillaries and choroid plexus
Kumagai, A. K., Dwyer, K. J., & Pardridge, W. M. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90328-x · Cited by 67 · cited 1×
“The higher molecular mass forms represent more heavily glycosylated transporters, which are concentrated in blood vessels, whereas the ;45 kDa form is expressed in glial cells (53).”
BackgroundNehlig, A., Porrino, L. J., Crane, A. M., & Sokoloff, L. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.54 · Cited by 60 · cited 1×
“glucose utilization in the rat brain (18, 19).”
BackgroundAdesanya, O. O., Zhou, J., & Bondy, C. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.5.8626866 · Cited by 58 · cited 1×
“The current investigation of estrogen’s effects on brain IGF1 and glucose transporter expression was stimulated by prior observations that estrogen increases IGF1 expression (55, 56) and glucose utilization in the uterus (57, 58).”
BackgroundSelf-citationHermann, E., Fleischer, B., Mayet, W.-J., Poralla, T., & Büschenfelde, K. ‐. M. Z. (1989) · PubMed · Cited by 50
Acute administration of high doses of estrogen increases glucose utilization throughout brain
Namba, H., & Sokoloff, L. (1984) · Brain Research · doi:10.1016/0006-8993(84)91276-9 · Cited by 50 · cited 2×
“glucose utilization in the rat brain (18, 19).”
BackgroundMatsuda, T., & Hirano, T. (1994) · Blood · doi:10.1182/blood.v83.12.3457.3457 · Cited by 50
Regulation of Glucose Transporters by Estradiol in the Immature Rat Uterus
Welch, R. D., & Gorski, J. (1999) · Endocrinology · doi:10.1210/endo.140.8.6923 · Cited by 44
Oh, J. (1996) · Cytokine · doi:10.1006/cyto.1996.0055 · Cited by 35
Estrogen Control of Uterine Carbohydrate Metabolism: Factors Affecting Glucose Utilization
Barker, K. L., Nielson, M. H., & Warren, J. C. (1966) · Endocrinology · doi:10.1210/endo-79-6-1069 · Cited by 33
Estrogen induction of insulin-like growth factors and myc proto-oncogene expression in the uterus
Murphy, L. J. (1991) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(91)90186-9 · Cited by 33 · cited 1×
“The current investigation of estrogen’s effects on brain IGF1 and glucose transporter expression was stimulated by prior observations that estrogen increases IGF1 expression (55, 56) and glucose utilization in the uterus (57, 58).”
BackgroundCascieri, M. A., Chicchi, G. G., Hayes, N. S., & Strader, C. D. (1986) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(86)90186-2 · Cited by 23
Zhou, J., Anderson, K., Bievre, M., Ng, S., & Bondy, C. A. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34090 · Cited by 19 · cited 1×
“uterus (55, 56) and mammary gland (63).”
Self-citationCornford, E. M., Hyman, S., Cornford, M. E., Damian, R. T., & Raleigh, M. J. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199807000-00007 · Cited by 13 · cited 5×
“One earlier study reported estrogen-induced increases in Glut1 expression in the BBB of the rat (29); however, the investigators examined time points within 24 h after a single E2 injection whereas we examined brains after 3 days of sustained treatment.”
BackgroundInfluentialSaldarini, R. J., & Yochim, J. M. (1968) · Endocrinology · doi:10.1210/endo-82-3-511 · Cited by 12 · cited 1×
“The current investigation of estrogen’s effects on brain IGF1 and glucose transporter expression was stimulated by prior observations that estrogen increases IGF1 expression (55, 56) and glucose utilization in the uterus (57, 58).”
BackgroundRa, G. (2000) · PubMed · Cited by 12
Research works printed but not linked: 3
- 10.1210/endo.133.6.8243275 · doi:10.1210/endo.133.6.8243275 · Paper page
- 10.1210/endo.135.5.7525251 · doi:10.1210/endo.135.5.7525251 · Paper page
- 10.1210/endo.132.4.8384986 · doi:10.1210/endo.132.4.8384986 · Paper page
Cited by
Estrogen deficiency and the origin of obesity during menopause
Lizcano, F., & Guzmán, G. (2014) · BioMed Research International · doi:10.1155/2014/757461 · Cited by 586
“Estrogens regulate glucose/energy metabolism via the direct and indirect control of the expression of enzymes that are involved in this process, such as hexokinase (HK), phosphoglucoisomerase (PGI), phosphofructokinase (PFK), aldolase (AD), glyceraldehyde 3-phosphate dehydrogenase (GAPD), phosphoglycerate kinase (PK)…”
BackgroundGlucose transporters in brain in health and disease
Koepsell, H. (2020) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-020-02441-x · Cited by 558
“It was observed that 17beta-estradiol increased the expression of Glut1 in the BBB of ovarectomized female rats [373] and the expression of GLUT1, GLUT3, and GLUT4 in brain of ovarectomized female rhesus monkeys [63].”
BackgroundEstrogen: A master regulator of bioenergetic systems in the brain and body
Rettberg, J. R., Yao, J., & Brinton, R. D. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2013.08.001 · Cited by 534
“Glucose transporter-4 (GLUT-4) is also expressed on neuronal membranes, and is unique because its translocation from the cytoplasmic compartment to the cell membrane is regulated by insulin.”
InfluentialÅberg, N. D., Brywe, K. G., & Isgaard, J. (2006) · The Scientific World JOURNAL · doi:10.1100/tsw.2006.22 · Cited by 387
The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications
Brinton, R. D. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.003 · Cited by 385
“Bondy and colleagues found that IGF-1R mRNA was concentrated in cortical neurons in a distribution similar to Gluts 3 and 4 [ 41 ].”
Influential
Metadata
- Authors
- CHENG, C. M., COHEN, M., WANG, J., & BONDY, C. A.
- Affiliations
- National Institutes of Health (US)
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2001-04
- Volume
- 15
- Issue
- 6
- Pages
- 907-915
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2135078756
- Cited by
- 115
- References
- 110
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 8 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 9 · 2012: 5
- FWCI
- 3.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- estrogen, glucose transporters, insulin-like growth factor I, IGF-1 receptor, tamoxifen, selective estrogen receptor modulators, estradiol, frontal cortex, rhesus monkeys, GLUT3, GLUT4, GLUT1, neuroprotection, menopause, Alzheimer's disease
- MeSH terms
- Animals, Cerebral Cortex, Estradiol, Female, Insulin-Like Growth Factor I, Macaca mulatta, Monosaccharide Transport Proteins, Muscle Proteins, Nerve Tissue Proteins, RNA, Messenger, Tamoxifen, Gene Expression, Receptor, IGF Type 1, Antineoplastic Agents, Hormonal, Glucose Transporter Type 3, Glucose Transporter Type 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.